---
title: PK Assays for Biologics and ADCs | Crystal Bio Solutions
description: "PK bioanalysis for mAbs, bispecifics and ADCs: total antibody, conjugated drug and free payload assays by LBA, LC-MS and hybrid methods, validated per ICH M10."
---

![Logo\_CBS-横版-原色(RGB)](https://www.crystalbiosolutions.com/hs-fs/hubfs/Logo_CBS-%E6%A8%AA%E7%89%88-%E5%8E%9F%E8%89%B2(RGB)-2.png?width=330&height=150&name=Logo_CBS-%E6%A8%AA%E7%89%88-%E5%8E%9F%E8%89%B2(RGB)-2.png)

- Bioanalysis & Biomarkers 
    - [Bioanalysis & Biomarker Services](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
    - [PK Assays for Biologics & ADCs](https://www.crystalbiosolutions.com/services/pk-bioanalysis)
    - [NAb & ADA Immunogenicity Assays](https://www.crystalbiosolutions.com/ada-and-nab-testing-in-biologics-pk-efficacy-and-regulatory-risk)
    - [Receptor Occupancy Assays](https://www.crystalbiosolutions.com/services/receptor-occupancy-assays)
- CMC & ADC Analytical 
    - [Characterization & CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
    - [ADC Analytical & Bioanalytical](https://www.crystalbiosolutions.com/antibody-drug-conjugates-adc)
- [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
- [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
- [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)

- [Resources](https://www.crystalbiosolutions.com/news-and-events)
- [About Us](https://www.crystalbiosolutions.com/about-us)
- [Request a Proposal](https://www.crystalbiosolutions.com/contact-us)

![Scientist loading a 96-well plate with a multichannel pipette during bioanalysis sample preparation.](https://www.crystalbiosolutions.com/hs-fs/hubfs/bioanalytical-and-biomarker.webp?width=960&height=640&name=bioanalytical-and-biomarker.webp)

# PK Assays for Biologics and ADCs

Crystal Bio Solutions, part of Crystal Group, develops, validates and runs pharmacokinetic (PK) assays for monoclonal and multispecific antibodies, antibody-drug conjugates (ADCs) and other biologics. We use ligand-binding assays, LC-MS and hybrid immunocapture LC-MS methods, choosing the platform for each analyte. Methods are validated following ICH M10, and sample analysis is performed in our GLP- and GCLP-compliant bioanalysis laboratory in Pleasanton, California.

[![Let's talk](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/146565877/interactive-264126601418.png)](https://www.crystalbiosolutions.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKkCeoI759PKJzJhqzFNKtVfVQIOCbuczggf%2FZs5ZPT8Vg3PkWbNB9ho%2B8POr9bP8V5hV2%2F36gY12QPz8N7rnEk6qAE7%2FltKvnIBp8dl9FfrJWevB1hr5UQkmg%2B6h8QjuQnANjdJW7Bcm9IopP6AsCrE9%2BAovI97gjfCvpIsEXgRNaT36TuU%2B1%2FmOduSBKjxV%2BMI6Id%2BAEo%2BbOqoSHFUgg3MxhU&webInteractiveContentId=264126601418&portalId=146565877&hsLang=en)

![CBS orange-blue banner-1](https://www.crystalbiosolutions.com/hs-fs/hubfs/CBS%20orange-blue%20banner-1.png?width=2000&height=21&name=CBS%20orange-blue%20banner-1.png "CBS orange-blue banner-1")

Total Antibody (TAb) Assays Quantification of all drug-derived antibody, regardless of conjugation state, for mAbs, bispecifics and ADCs. Conjugated Antibody and Payload Assays for antibody-conjugated drug, using ligand-binding or hybrid immunocapture LC-MS methods when specificity is critical. Free Payload by LC-MS/MS Quantification of unconjugated payload and its metabolites using triple quadrupole LC-MS/MS. Ligand-Binding Assays ELISA, MSD, Gyrolab, Luminex and SP-X platforms for sensitive quantification of large molecules in biological matrices. LC-MS and Hybrid Methods High-resolution and triple quadrupole LC-MS, including hybrid LBA/LC-MS, for cases where ligand-binding assays fall short or critical reagents are not available. ICH M10 Validation and Sample Analysis Method development, validation following ICH M10, and nonclinical and clinical sample analysis with eCTD-ready reports.

![CBS orange banner-1](https://www.crystalbiosolutions.com/hs-fs/hubfs/website-assets/CBS%20orange%20banner-1.png?width=2000&height=24&name=CBS%20orange%20banner-1.png "CBS orange banner-1")

![Scientist working in a bioanalysis laboratory](https://www.crystalbiosolutions.com/hs-fs/hubfs/pexels-pavel-danilyuk-8442153.jpg?width=640&height=480&name=pexels-pavel-danilyuk-8442153.jpg) Multi-Analyte PK Strategy for ADCs ADC exposure cannot be described by one analyte. A typical PK strategy measures three:

- **Total antibody**, describing the antibody backbone
- **Conjugated antibody or conjugated payload**, describing the active drug
- **Unconjugated (free) payload**, related to potential off-target toxicity

Comparing these analytes over time shows deconjugation in circulation. CBS plans these assays together with DAR and stability characterization from our Natick, Massachusetts CMC laboratory and with immunogenicity assessment, so the data can be interpreted as one package.

## Related Services

Bioanalysis & Biomarkers PK, immunogenicity and biomarker assays for biologics and novel modalities. ADC Analytical & Bioanalytical DAR, conjugation, payload stability and ADC bioanalysis. NAb and ADA Assays Immunogenicity assay development, validation and sample analysis. Receptor Occupancy Assays Flow cytometry RO assays to measure target engagement.

## Frequently Asked Questions

 

### What is a PK assay?

A pharmacokinetic (PK) assay measures drug concentrations in biological samples such as serum or plasma over time. The data describe absorption, distribution and clearance, and support dose selection, safety margins and exposure-response analysis in nonclinical and clinical studies.

 

### What is a total antibody (TAb) assay?

A total antibody assay quantifies all drug-derived antibody in a sample, regardless of conjugation state or target binding. It is a core PK analyte for ADCs and bispecific antibodies, where it is interpreted alongside conjugated-drug and free-payload measurements.

 

### Which analytes are measured in ADC PK studies?

ADC PK typically requires total antibody (conjugated and unconjugated), conjugated antibody or conjugated payload, and unconjugated (free) payload. Together they describe exposure, deconjugation in circulation and potential payload-related toxicity.

 

### When is LC-MS preferred over a ligand-binding assay for PK?

Ligand-binding assays offer high sensitivity for large molecules and are the usual choice for antibodies. LC-MS is preferred when specificity matters more than raw sensitivity, for example for ADC payloads, peptides and oligonucleotides, or when critical reagents for a ligand-binding assay are not available. Hybrid methods combine immunocapture with LC-MS detection.

 

### What does ICH M10 require for PK assay validation?

ICH M10 sets expectations for validating chromatographic and ligand-binding assays used for regulatory PK and toxicokinetic data, including selectivity, specificity, calibration curve, accuracy, precision, sensitivity, dilution linearity, stability and, for ligand-binding assays, parallelism where relevant. It also covers incurred sample reanalysis and reporting.

 

### Can PK assays be affected by anti-drug antibodies?

Yes. Anti-drug antibodies can bind the drug and interfere with its detection, or change its clearance. PK and immunogenicity assays are therefore designed and interpreted together, and assay format choices consider drug and ADA tolerance.

 

### Where does Crystal Bio Solutions perform PK sample analysis?

PK method development, validation and sample analysis are performed in the CBS GLP- and GCLP-compliant bioanalysis laboratory in Pleasanton, California. ADC characterization and CMC analytical work are performed at our Natick, Massachusetts laboratory.

 

## Have a Question?

Connect with our experts and get started on your project today.

[![Free Consultation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/146565877/interactive-270508115133.png)](https://www.crystalbiosolutions.com/hs/cta/wi/redirect?encryptedPayload=AVxigLKvHmXdxAeaM3AmNKZPGfqiOMKtQFunFEn8t8ljNskslCBd0VKruOQzjIy7pu7xpzKIn5%2BRRDgTaZHl69CFNOkmpy%2FLEwLIEak74x14WZTX87KnRQ0B16Y9tKIj%2BGs6iG7mLQ%2FVooDV4IxOAfXyGrJuE73tN0awspSKOMBYBif53%2B1hMTrAReiJFfADHbRz7gjYGId8KimPJbjn%2FVP12Sn2CBBI&webInteractiveContentId=270508115133&portalId=146565877&hsLang=en)

![Logo\_CBS-竖版-反白](https://www.crystalbiosolutions.com/hubfs/Logo_CBS-%E7%AB%96%E7%89%88-%E5%8F%8D%E7%99%BD.png)

- [Our Services](https://www.crystalbiosolutions.com) 
    - [Bioanalysis and Biomarker](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers)
    - [CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical)
    - [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology)
    - [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt)
    - [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services)
- [Information](https://www.crystalbiosolutions.com/news-and-events) 
    - [Resources](https://www.crystalbiosolutions.com/news-and-events)
    - [News & Events](https://www.crystalbiosolutions.com/news-and-events)
    - [Careers](https://www.crystalbiosolutions.com/careers-at-crystal-bio-solutions)
    - [About us](https://www.crystalbiosolutions.com/about-us)
- [Contact](https://www.crystalbiosolutions.com/contact-us) 
    - [Email \>](mailto:cbs_bd@crystalpharmatech.com)
    - [Contact Form](https://www.crystalbiosolutions.com/contact-us)
    - [Our Locations](https://www.crystalbiosolutions.com/locations)
    - [Crystal Group \>](https://www.crystalpharmatech.com/) 
          - [Crystal Pharmatech](https://www.crystalpharmatech.com/)
          - [Crystal NAX](https://www.crystalnax.com/)

<https://www.linkedin.com/company/crystal-bio-solutions/> <https://x.com/crystalbiosol> <https://www.facebook.com/people/Crystal-Bio-Solutions/61579857412775/> <https://www.instagram.com/crystalbiosol/> <https://bsky.app/profile/crystalbiosol.bsky.social>

- [Privacy Policy](https://www.crystalbiosolutions.com/policies/privacy-policy)
- [Terms of Service](https://www.crystalbiosolutions.com/policies/terms-of-service)

Copyright © 2026 Crystal Bio Solutions, All rights reserved

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/#organization",
  "@type" : "Organization",
  "alternateName" : "CBS",
  "contactPoint" : [ {
    "@type" : "ContactPoint",
    "contactType" : "sales",
    "email" : "cbs_bd@crystalpharmatech.com",
    "url" : "https://www.crystalbiosolutions.com/contact-us"
  } ],
  "logo" : "https://www.crystalbiosolutions.com/hs-fs/hubfs/CBS%20VI%20v2/CBS%20Logo.png",
  "name" : "Crystal Bio Solutions",
  "parentOrganization" : {
    "@type" : "Organization",
    "name" : "Crystal Group",
    "url" : "https://www.crystalpharmatech.com/"
  },
  "sameAs" : [ "https://www.linkedin.com/company/crystal-bio-solutions/", "https://x.com/crystalbiosol", "https://www.facebook.com/people/Crystal-Bio-Solutions/61579857412775/", "https://www.instagram.com/crystalbiosol/", "https://bsky.app/profile/crystalbiosol.bsky.social" ],
  "url" : "https://www.crystalbiosolutions.com/"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/#website",
  "@type" : "WebSite",
  "inLanguage" : "en",
  "name" : "Crystal Bio Solutions",
  "publisher" : {
    "@id" : "https://www.crystalbiosolutions.com/#organization"
  },
  "url" : "https://www.crystalbiosolutions.com/"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#webpage",
  "@type" : "WebPage",
  "about" : {
    "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#service"
  },
  "breadcrumb" : {
    "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#breadcrumb"
  },
  "description" : "PK bioanalysis for mAbs, bispecifics and ADCs: total antibody, conjugated drug and free payload assays by LBA, LC-MS and hybrid methods, validated per ICH M10.",
  "inLanguage" : "en",
  "isPartOf" : {
    "@id" : "https://www.crystalbiosolutions.com/#website"
  },
  "name" : "PK Assays for Biologics and ADCs | Crystal Bio Solutions",
  "url" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#service",
  "@type" : "Service",
  "areaServed" : "Worldwide",
  "description" : "Development, ICH M10 validation and sample analysis of pharmacokinetic assays for antibodies, multispecifics and ADCs, including total antibody, conjugated drug and free payload, by LBA, LC-MS and hybrid methods.",
  "hasOfferCatalog" : {
    "@type" : "OfferCatalog",
    "itemListElement" : [ {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "Total antibody (TAb) assays"
      }
    }, {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "Conjugated antibody and conjugated payload assays"
      }
    }, {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "Free payload quantification by LC-MS/MS"
      }
    }, {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "Ligand-binding assays (ELISA, MSD, Gyrolab, Luminex, SP-X)"
      }
    }, {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "LC-MS and hybrid LBA/LC-MS"
      }
    }, {
      "@type" : "Offer",
      "itemOffered" : {
        "@type" : "Service",
        "name" : "ICH M10 method validation and sample analysis"
      }
    } ],
    "name" : "PK Assays for Biologics and ADCs"
  },
  "name" : "PK Assays for Biologics and ADCs",
  "provider" : {
    "@id" : "https://www.crystalbiosolutions.com/#organization"
  },
  "url" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#breadcrumb",
  "@type" : "BreadcrumbList",
  "itemListElement" : [ {
    "@type" : "ListItem",
    "item" : "https://www.crystalbiosolutions.com/",
    "name" : "Home",
    "position" : 1
  }, {
    "@type" : "ListItem",
    "item" : "https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers",
    "name" : "Bioanalysis & Biomarkers",
    "position" : 2
  }, {
    "@type" : "ListItem",
    "item" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis",
    "name" : "PK Assays for Biologics and ADCs",
    "position" : 3
  } ]
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.crystalbiosolutions.com/services/pk-bioanalysis/#faq",
  "@type" : "FAQPage",
  "mainEntity" : [ {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "A pharmacokinetic (PK) assay measures drug concentrations in biological samples such as serum or plasma over time. The data describe absorption, distribution and clearance, and support dose selection, safety margins and exposure-response analysis in nonclinical and clinical studies."
    },
    "name" : "What is a PK assay?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "A total antibody assay quantifies all drug-derived antibody in a sample, regardless of conjugation state or target binding. It is a core PK analyte for ADCs and bispecific antibodies, where it is interpreted alongside conjugated-drug and free-payload measurements."
    },
    "name" : "What is a total antibody (TAb) assay?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "ADC PK typically requires total antibody (conjugated and unconjugated), conjugated antibody or conjugated payload, and unconjugated (free) payload. Together they describe exposure, deconjugation in circulation and potential payload-related toxicity."
    },
    "name" : "Which analytes are measured in ADC PK studies?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "Ligand-binding assays offer high sensitivity for large molecules and are the usual choice for antibodies. LC-MS is preferred when specificity matters more than raw sensitivity, for example for ADC payloads, peptides and oligonucleotides, or when critical reagents for a ligand-binding assay are not available. Hybrid methods combine immunocapture with LC-MS detection."
    },
    "name" : "When is LC-MS preferred over a ligand-binding assay for PK?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "ICH M10 sets expectations for validating chromatographic and ligand-binding assays used for regulatory PK and toxicokinetic data, including selectivity, specificity, calibration curve, accuracy, precision, sensitivity, dilution linearity, stability and, for ligand-binding assays, parallelism where relevant. It also covers incurred sample reanalysis and reporting."
    },
    "name" : "What does ICH M10 require for PK assay validation?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "Yes. Anti-drug antibodies can bind the drug and interfere with its detection, or change its clearance. PK and immunogenicity assays are therefore designed and interpreted together, and assay format choices consider drug and ADA tolerance."
    },
    "name" : "Can PK assays be affected by anti-drug antibodies?"
  }, {
    "@type" : "Question",
    "acceptedAnswer" : {
      "@type" : "Answer",
      "text" : "PK method development, validation and sample analysis are performed in the CBS GLP- and GCLP-compliant bioanalysis laboratory in Pleasanton, California. ADC characterization and CMC analytical work are performed at our Natick, Massachusetts laboratory."
    },
    "name" : "Where does Crystal Bio Solutions perform PK sample analysis?"
  } ]
}
```